Fresenius Kabi and Halyard Health Enter Distribution Agreement
By HospiMedica International staff writers Posted on 03 Feb 2015 |
Image: The Homepump Eclipse ambulatory infusion system (Photo courtesy of Halyard Health).
Fresenius Kabi (Bad Homburg, Germany), a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition, has signed a multi-year supply and distribution and agreement for Halyard Health (Alpharetta, GA, USA) disposable elastomeric intravenous (IV) infusion pumps.
The Halyard Health IV ambulatory infusion pumps include the Homepump Eclipse system, which is designed for antibiotic therapy, providing delivery times ranging from 30 minutes to 5 hours; the Homepump C-Series system is designed for continuous infusion, with delivery times ranging from 1 to 11 days, and is intended for chemotherapy and other protocols. Both systems provide medication through a catheter, but due to their light weight, compact size, and proven ease of use, they allow patients to receive the therapy in the comfort of their own homes.
“This agreement demonstrates the company’s continued commitment to our philosophy of ‘caring for life’,” said Christian Hauer, president of the medical devices division of Fresenius Kabi. “By partnering with Halyard Health, we will be able to offer our customers an expanded range of products centered on key intravenously administered therapies, such as oncology and antibiotic treatment.”
The multi-year agreement with Halyard Health (formerly Kimberly-Clark Healthcare) covers several European markets, including Germany, Spain, Poland, Switzerland, and Austria. The United Kingdom and Ireland, which were already part of a multi-year distribution arrangement between Fresenius Kabi and Halyard Health, will also now come under the terms of this larger agreement.
Related Links:
Fresenius Kabi
Halyard Health
The Halyard Health IV ambulatory infusion pumps include the Homepump Eclipse system, which is designed for antibiotic therapy, providing delivery times ranging from 30 minutes to 5 hours; the Homepump C-Series system is designed for continuous infusion, with delivery times ranging from 1 to 11 days, and is intended for chemotherapy and other protocols. Both systems provide medication through a catheter, but due to their light weight, compact size, and proven ease of use, they allow patients to receive the therapy in the comfort of their own homes.
“This agreement demonstrates the company’s continued commitment to our philosophy of ‘caring for life’,” said Christian Hauer, president of the medical devices division of Fresenius Kabi. “By partnering with Halyard Health, we will be able to offer our customers an expanded range of products centered on key intravenously administered therapies, such as oncology and antibiotic treatment.”
The multi-year agreement with Halyard Health (formerly Kimberly-Clark Healthcare) covers several European markets, including Germany, Spain, Poland, Switzerland, and Austria. The United Kingdom and Ireland, which were already part of a multi-year distribution arrangement between Fresenius Kabi and Halyard Health, will also now come under the terms of this larger agreement.
Related Links:
Fresenius Kabi
Halyard Health
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures